Long Term Outcomes of OCT Guided PCI in STEMI patients

Prior studies have shown the use of optical coherence tomography (OCT) have a significant influence on decision making, optimizing PCI and improving outcomes, vs conventional PCI. However, these studies have focused mainly on patients with stable angina or non-ST elevation MI. 

Resultados a largo plazo de la utilización de OCT para guiar ATC en pacientes con IAMCEST

The aim of this retrospective study was to find out whether the use of OCT can reduce mortality at long term (5 years) vs. PCI alone in patients with ST elevation MI (STEMI). 

Primary end point was all-cause mortality rate, and secondary end point was cardiovascular mortality rate.

3,897 were enrolled: 69.2% were treated with OCT and 30.8% with PCI alone. Mean patient age was approximately 60, and most patients were men. Among OCT patients, the most affected artery was the anterior descending, while in the PCI alone group, it was the right coronary. 

OCT guided patients were treated with stents less frequently during PCI (62.6% vs 80.2%; p<0.001). At 5 years, accumulated all-cause mortality and cardiovascular rates in the OCT guided cohort were 10.4% and 8.0%, respectively, significantly lower than the PCI alone cohort (19.0% and 14.1%; p<0.001).

Read also: Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap.

Multivariable models showed the use of OCT might significantly reduce all-cause mortality at 5 years (HR: 0.689, CI 95%: 0.551-0.862) and cardiovascular mortality (HR: 0.692, IC 95%: 0.536-0.895). After propensity score matching for homogenous samples, the benefits of OCT guided PCI remained consistent in terms of all-cause (HR: 0.707, CI 95%: 0.548-0.913) and cardiovascular mortality (HR: 0.709, CI 95%: 0.526-0.955).

Conclusion

In this observational study, the use of OCT during PCI in patients with STEMI was associated to reduced mortality at long term vs. PCI alone. However, we need prospective randomized studies to confirm these results. 

Original Title: Five-year follow-up of OCT-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Reference: Luping He, MD et al EuroIntervention 2024;20:e937-e947.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...